Lexpos News

/Lexpos News

Expiry of SSP086 Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free

The Department of Health and Social Care (DHSC) has confirmed the Serious Shortage Protocol (SSP086) for Latanoprost 50 micrograms/ml / Timolol 5 mg/ml (Fixapost®) eye drops 0.2 ml unit dose preservative‑free will expire at 23:59pm Friday 23rd January 2026  SSP086 was originally set to expire on 6th February 2026 but its expiry date has been brought forward because [...]

The post Expiry of SSP086 Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free appeared first on Community Pharmacy England.

By |January 22nd, 2026|Lexpos News|Comments Off on Expiry of SSP086 Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free

New patient-facing website to promote NHS pharmacy clinical services

Community Pharmacy England has launched a new patient-facing website to promote several of the key Advanced services that pharmacy teams provide and to direct patients to pharmacies in England that provide these services. The website (communitypharmacy.org.uk) provides information about the following three services: Pharmacy First Service (clinical pathways); Hypertension Case-Finding Service (publicly known as the [...]

The post New patient-facing website to promote NHS pharmacy clinical services appeared first on Community Pharmacy England.

By |January 22nd, 2026|Lexpos News|Comments Off on New patient-facing website to promote NHS pharmacy clinical services

Data Security & Protection Toolkit 2026: Community Pharmacy England guidance available

Community Pharmacy England has published new guidance to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Tuesday 30th June 2026. Community Pharmacy England has collaborated with the NHS DSPTK team to keep the workload associated [...]

The post Data Security & Protection Toolkit 2026: Community Pharmacy England guidance available appeared first on Community Pharmacy England.

By |January 21st, 2026|Lexpos News|Comments Off on Data Security & Protection Toolkit 2026: Community Pharmacy England guidance available

MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug Alert Number: EL(26)A/02 Date issued: 21 January 2026 Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule [...]

The post MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

By |January 21st, 2026|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Second national health campaign starts soon

The second 2025/26 national health campaign starts in just over a weeks time (Monday 2nd February 2026). All pharmacies will need to participate in the campaign, using relevant materials to promote the Pharmacy First service to the public. How to meet the requirements of the campaign Pharmacy owners can meet the requirements of the campaign [...]

The post Second national health campaign starts soon appeared first on Community Pharmacy England.

By |January 21st, 2026|Lexpos News|Comments Off on Second national health campaign starts soon